Short Interest To Observe: Biostar Pharmaceuticals Incorporated (NASDAQ:BSPM) on Focus After Report of More Shorts

November 28, 2016 - By Marguerite Chambers   ·   0 Comments

Short Interest To Observe: Biostar Pharmaceuticals Incorporated (NASDAQ:BSPM) on Focus After Report of More Shorts

The stock of Biostar Pharmaceuticals Incorporated (NASDAQ:BSPM) registered an increase of 22.48% in short interest. BSPM’s total short interest was 307,300 shares in November as published by FINRA. Its up 22.48% from 250,900 shares, reported previously. With 1.06M shares average volume, it will take short sellers 0 days to cover their BSPM’s short positions. The short interest to Biostar Pharmaceuticals Incorporated’s float is 16.7%. About 54,527 shares traded hands. Biostar Pharmaceuticals Inc (NASDAQ:BSPM) has risen 131.97% since April 25, 2016 and is uptrending. It has outperformed by 125.96% the S&P500.

Biostar Pharmaceuticals, Inc. is a holding company. The company has a market cap of $7.89 million. The Company, through its subsidiary, Shaanxi Biostar Biotech, Ltd. (Shaanxi Biostar), and its variable interest entities (VIEs), Shaanxi Aoxing Pharmaceutical Co., Ltd. (Aoxing Pharmaceutical) and Shaanxi Weinan Huaren Pharmaceuticals Ltd. (Shaanxi Weinan), develops, makes and markets pharmaceutical products for various diseases and conditions in the People’s Republic of China (PRC or China). It currently has negative earnings. The Firm offers over-the-counter (OTC) products and prescription pharmaceuticals.

BSPM Company Profile

Biostar Pharmaceuticals, Inc. (Biostar), incorporated on March 27, 2007, is a holding company. The Company, through its subsidiary, Shaanxi Biostar Biotech, Ltd. (Shaanxi Biostar), and its variable interest entities (VIEs), Shaanxi Aoxing Pharmaceutical Co., Ltd. (Aoxing Pharmaceutical) and Shaanxi Weinan Huaren Pharmaceuticals Ltd. (Shaanxi Weinan), develops, makes and markets pharmaceutical products for various diseases and conditions in the People’s Republic of China (PRC or China). The Firm offers over-the-counter (OTC) products and prescription pharmaceuticals. The Company’s products are derived from medicinal herbs that are either grown at its own facility or purchased from its suppliers. The Company’s products are sold in approximately 30 provinces in the PRC through a network of over 60 distributors and through approximately 230 sales people.

More notable recent Biostar Pharmaceuticals Inc (NASDAQ:BSPM) news were published by: Prnewswire.com which released: “Biostar Pharmaceuticals, Inc. Announces Its Quarterly Results for Three Months …” on November 21, 2016, also Prnewswire.com with their article: “Biostar Pharmaceuticals, Inc. Announces Its Quarterly Results for Three Months …” published on August 22, 2016, Marketwatch.com published: “/quotes/zigman/3870025/realtime” on December 27, 2010. More interesting news about Biostar Pharmaceuticals Inc (NASDAQ:BSPM) were released by: Prnewswire.com and their article: “Biostar Pharmaceuticals Completes Previously Announced Registered Direct Financing” published on October 18, 2016 as well as Prnewswire.com‘s news article titled: “Drug Makers Stocks on Investors’ Radar — Immune Pharma, Sanofi, Biostar …” with publication date: November 28, 2016.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By Marguerite Chambers


Readers Comments (0)





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>